OverviewSuggest Edit

Bausch Health (also known as Bausch Health Companies, formerly known as Valeant Pharmaceuticals) is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers vision care, surgical, consumer, and ophthalmology Rx products; Solta products, branded and generic pharmaceutical products, OTC products, medical devices, and Bausch + Lomb products. The Salix segment provides gastroenterology products. The Ortho Dermatologics segment offers dermatological products and Solta medical aesthetic devices. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products.
TypePublic
Founded1959
HQLaval, CA
Websitebauschhealth.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Dec 2019)21,700(+3%)
Job Openings9
Revenue (FY, 2020)$8 B(-6%)
Share Price (Sept 2021)C$36.4(-1%)
Cybersecurity ratingBMore

Key People/Management at Bausch Health

Joseph C. Papa

Joseph C. Papa

Chairman of the Board, Chief Executive Officer
Louis Yu

Louis Yu

Chief Quality Officer
Paul S. Herendeen

Paul S. Herendeen

Executive Vice President and Chief Financial Officer
Tage Ramakrishna

Tage Ramakrishna

Chief Medical Officer, President, R&D
Joseph Gordon

Joseph Gordon

President & Co-Head, Bausch + Lomb/International
Scott Hirsch

Scott Hirsch

Senior Vice President, Chief Strategy Officer
Show more

Bausch Health Office Locations

Bausch Health has offices in Laval, Steinbach, Bridgewater Township, Clearwater and in 38 other locations
Laval, CA (HQ)
2150 St. Elzéar Blvd. West
Steinbach, CA
100 Life Sciences Pkwy
Buenos Aires, AR
Av. del Libertador 174
Wien, AT
Office Park I, Top B02
Sarajevo, BA
Tower A, Fra Anđela Zvizdovića 1
Indaiatuba, BR
Alameda Capovilla, 129 - Recreio Campestre Jóia
Show all (45)

Bausch Health Financials and Metrics

Bausch Health Revenue

Bausch Health's revenue was reported to be $8.03 b in FY, 2020
USD

Revenue (Q1, 2021)

2.0b

Net income (Q1, 2021)

(607.0m)

EBIT (Q1, 2021)

(221.0m)

Market capitalization (14-Sept-2021)

13.0b

Closing stock price (14-Sept-2021)

36.4

Cash (31-Mar-2021)

679.0m

EV

36.1b
Bausch Health's current market capitalization is C$13 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

8.7b8.4b8.6b8.0b

Revenue growth, %

(10%)(4%)3%

Cost of goods sold

2.5b2.4b2.4b

Gross profit

6.2b6.0b6.3b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.0b2.1b2.1b2.0b2.2b2.2b2.0b1.7b2.1b2.0b

Cost of goods sold

573.0m594.0m582.0m537.0m594.0m584.0m519.0m495.0m590.0m

Gross profit

1.4b1.5b1.6b1.5b1.6b1.6b1.5b1.2b1.5b

Gross profit Margin, %

71%72%73%73%72%74%74%70%72%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

720.0m721.0m3.2b

Accounts Receivable

2.1b1.9b1.8b

Prepaid Expenses

771.0m689.0m779.0m

Inventories

1.0b934.0m1.1b
Quarterly
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

2.4b(4.1b)(1.8b)(559.0m)

Depreciation and Amortization

2.9b2.8b2.1b1.8b

Inventories

7.0m(5.0m)(209.0m)(77.0m)

Accounts Payable

387.0m(121.0m)(149.0m)(471.0m)
USDFY, 2017

Revenue/Employee

421.4k

Debt/Equity

4.3 x

Debt/Assets

0.7 x

Financial Leverage

6.3 x

P/E Ratio

3.0
Show all financial metrics

Bausch Health Operating Metrics

FY, 2017FY, 2018FY, 2019Feb, 2021

Products

1.6 k1.5 k1.4 k

Product Brands

8890101

Manufacturing Facilities

403837

Trademarks

170
Show all operating metrics

Bausch Health Acquisitions / Subsidiaries

Company NameDateDeal Size
Synergetics USASeptember 02, 2015
Sprout PharmaceuticalsAugust 20, 2015$1 b
Amoun PharmaceuticalJuly 17, 2015$800 m
Salix PharmaceuticalsFebruary 22, 2015
DendreonFebruary 20, 2015$495 m
Valeo MedicalAugust 25, 2014
PreCision DermatologyFebruary 03, 2014
Solta MedicalDecember 16, 2013
Bausch & LombMay 28, 2013$8.7 b
Obagi Medical ProductsMarch 20, 2013$344 m
Show more

Bausch Health Revenue Breakdown

Embed Graph

Bausch Health revenue breakdown by business segment: 14.7% from Diversified Products, 6.5% from Ortho Dermatologics, 23.3% from Salix, 54.6% from Bausch + Lomb/International and 1.0% from Other

Bausch Health revenue breakdown by geographic segment: 60.6% from U.S. and Puerto Rico and 39.4% from Other

Human Capital Metrics

Embed Graph
Show all human capital metrics

Bausch Health Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Bausch Health Online and Social Media Presence

Embed Graph

Bausch Health News and Updates

Anaqua Delivers Enhanced IP Management to Bausch Health

Anaqua’s AQX platform to provide patent and trademark management with integrated IP analytics Anaqua’s AQX platform to provide patent and trademark management with integrated IP analytics

Bausch Health files confidentially for IPOs of eye care business and medical aesthetics business

Bausch Health Cos. Inc. said Monday it has filed confidentially for the initial public offerings of its eye health business Bausch & Lomb, and its medical aesthetics business Global Solta. The company has not yet set terms for either deal, but expects them to completed on previously communicate…

Eyewear Market: Y-O-Y Growth Rate is Expected to Increase by 13.03% | Top Vendors Include Bausch Health Companies Inc., Carl Zeiss AG, and De Rigo Vision Spa, Among Others| Analyzing Growth in Apparel, Accessories & Luxury Goods Industry | Technavio

NEW YORK, Aug. 28, 2021 /PRNewswire/ -- The "Eyewear Market by Product and Geography - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Bausch Health Companies Inc. (“Bausch or the “Company”) (NYSE: BHC).   Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

Global Chemical Peel Market (2021 to 2025) - Featuring AbbVie, Bausch Health Companies and L'Oreal Among Others

Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Global Chemical Peel Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Show more

Bausch Health Frequently Asked Questions

  • When was Bausch Health founded?

    Bausch Health was founded in 1959.

  • Who are Bausch Health key executives?

    Bausch Health's key executives are Joseph C. Papa, Louis Yu and Paul S. Herendeen.

  • How many employees does Bausch Health have?

    Bausch Health has 21,700 employees.

  • What is Bausch Health revenue?

    Latest Bausch Health annual revenue is $8 b.

  • What is Bausch Health revenue per employee?

    Latest Bausch Health revenue per employee is $369.9 k.

  • Who are Bausch Health competitors?

    Competitors of Bausch Health include Pfizer, Merck and Novartis.

  • Where is Bausch Health headquarters?

    Bausch Health headquarters is located at 2150 St. Elzéar Blvd. West, Laval.

  • Where are Bausch Health offices?

    Bausch Health has offices in Laval, Steinbach, Bridgewater Township, Clearwater and in 38 other locations.

  • How many offices does Bausch Health have?

    Bausch Health has 45 offices.